Large-scale testing (Phase 3)Ended earlyNCT00839917What this trial is testingProQuad™ in Healthy Children in Korea (V221-023)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT00578175What this trial is testingImmunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of AgeWho this might be right forVaricellaRubellaMumps+1 more GlaxoSmithKline 1,851
Large-scale testing (Phase 3)Study completedNCT00751348What this trial is testingImmunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136Who this might be right forMeaslesVaricellaMumps+1 more GlaxoSmithKline 475
Large-scale testing (Phase 3)Study completedNCT00109343What this trial is testingV221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 1,027
Testing effectiveness (Phase 2)Ended earlyNCT00258726What this trial is testingImmune Responses to Two Dose Varivax +/- MMR-IIWho this might be right forMeaslesMumpsRubella+1 more National Institute of Allergy and Infectious Diseases (NIAID) 105
Post-approval studies (Phase 4)UnknownNCT05952505What this trial is testingImmunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated VaccinesWho this might be right forSARS-CoV-2 InfectionVaricellaMeasles+2 more Shanghai Municipal Center for Disease Control and Prevention 540
Post-approval studies (Phase 4)Study completedNCT00432731What this trial is testingSafety Study of a Refrigerator-stable Formulation of VARIVAX®Who this might be right forVaricellaMeaslesMumps+1 more Merck Sharp & Dohme LLC 500
Testing effectiveness (Phase 2)Study completedNCT04398706What this trial is testingStudy of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsWho this might be right forPneumococcal ImmunisationDiphtheria ImmunisationTetanus Immunisation+8 more Sanofi Pasteur, a Sanofi Company 852
Large-scale testing (Phase 3)Study completedNCT00985166What this trial is testingProQuad in Healthy 4 to 6 Year Old Children (V221-014)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 801
Large-scale testing (Phase 3)Study completedNCT00626327What this trial is testingSafety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy ToddlersWho this might be right forMeningococcal Infections Novartis Vaccines 1,630
Large-scale testing (Phase 3)Study completedNCT01506193What this trial is testingImmunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenWho this might be right forRubellaVaricellaMeasles+1 more GlaxoSmithKline 716
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Large-scale testing (Phase 3)Study completedNCT00384397What this trial is testing2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersWho this might be right forMeningococcal MeningitisMeaslesMumps+2 more Sanofi Pasteur, a Sanofi Company 1,128
Not applicableLooking for participantsNCT05923970What this trial is testingIs a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?Who this might be right forVaccination FailureVaccine Response Impaired University of Alberta 200
Large-scale testing (Phase 3)Study completedNCT00402831What this trial is testingProQuad® Intramuscular vs SubcutaneousWho this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 405
Large-scale testing (Phase 3)Looking for participantsNCT07406360What this trial is testingA Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeWho this might be right forMeaslesMeasles-Mumps-Rubella+Chickenpox Vaccine GlaxoSmithKline 1,209